DSIP FAQ: common questions answered
An experimental sleep peptide with small, mixed human studies and no FDA-approved dose.
Also called: Delta sleep-inducing peptide, Delta-sleep-inducing peptide, Emideltide.
Sleep peptides · Experimental nine-amino-acid peptide with uncertain sleep-signaling targets.
- Is DSIP FDA-approved? No FDA-approved product or dose. Category 2 removal was not approval. An advisory vote does not change compounding law.
- How do people take it? Under the skin, once nightly. One poster described a four-week cycle. Source: reported by users, not an established dose.
- What's the difference between DSIP and CJC-1295 without DAC? DSIP: an experimental sleep peptide with small, mixed human studies and no FDA-approved dose. CJC-1295 without DAC: a peptide intended to trigger growth hormone release, with no human dosing study found. Why people pair them: users add DSIP hoping to improve deep sleep alongside a growth-hormone-release regimen.
- Can I take it with CJC-1295 without DAC? Users add DSIP hoping to improve deep sleep alongside a growth-hormone-release regimen. No human trial of this sleep stack was found. Heart-rate, glucose and fluid-related risks cannot be inferred from a sleep tracker. Source: reported by users. Ask a doctor before combining anything.
- Is it banned in sport? It is unclear (WADA 2026). S0 prohibits drugs without approval by any government health authority. Relevant foreign approval status was not resolved; ask the anti-doping authority.
- How long does a mixed vial last? No verified DSIP-specific after-mixing shelf life was found. A clear solution does not establish sterility or potency.
Related to DSIP
- Ipamorelin: An experimental peptide that triggers growth hormone release.
- Selank: A Russian nasal anxiety peptide with uncertain long-term benefit and safety.
- CJC-1295 without DAC: A peptide intended to trigger growth hormone release, with no human dosing study found.
- Pinealon: A peptide with unproven brain benefits and no established injection dose.
Sources
- 503B Bulk Drug Substances List, FDA · FDA · 2026
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act, FDA · FDA · 2026
- Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act, FDA · FDA · 2026
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks, FDA · FDA · 2026
- Download medicine data, European Medicines Agency · European Medicines Agency · 2026
- FDA Briefing Document: Emideltide-Related Bulk Drug Substances (Emideltide (free base) and Emideltide acetate), U.S. Food and Drug Administration · 2026
- MHRA Products | Home, MHRA · MHRA · 2026
- Sepsis, NHS · 2026
- The 2026 Prohibited List, World Anti-Doping Agency · WADA · 2026
- Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026, Australian Government · Australian Government · 2026
- Think twice before injecting peptides bought online: unauthorized products can seriously harm you, Health Canada · Health Canada · 2026
- Anaphylaxis, NHS · NHS · 2023
- Low blood sugar (hypoglycaemia), NHS · 2023
- [Using deltalicin for the treatment of patients with diabetic retinopathy]., Kresiun NV et al. · Eksperimental'naia i klinicheskaia farmakologiia · 2014
- The influence of deltalycyn and transcranial cerebellar stimulation upon recovery of retina after photo stress in patients with diabetic retinopathy., Kresyun NV et al. · Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi · 2014
Sources checked: 2026-10-18.
Information only, not medical advice. Peptifacts does not sell anything and does not link to sellers.